If a company is only investing in AI without having a technology platform backbone, that's like putting lipstick on a pig. Technology platforms are an essential first step before embarking on AI ...
(RTTNews) - Sarepta Therapeutics (SRPT), Wednesday announced that the FDA has designated its rAAVrh74 viral vector used in the investigational gene therapy SRP-9003 for limb-girdle muscular dystrophy ...
The FDA has designated the viral vector rAAVrh74, which Sarepta Therapeutics, Inc. (NASDAQ:SRPT) uses in its gene therapy candidate SRP-9003 for limb-girdle muscular dystrophy type 2E/R4 (LGMD2E/R4), ...
Microglia are specialized immune cells that make up around 10 % of all cells in the brain and spinal cord. They work by removing pathogenic bacteria, dead cells, aggregated proteins, and soluble ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results